| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b523a286f92340af778b1e93ae73169e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14248
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1723
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-63 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H40-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-14 |
| filingDate |
2022-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1948118b6a854ad7926b055a8fe2cc23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f86345333b7479a23aaf60d285512c39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93542eaa1558cb325b500c106b0d50a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80b50e439a024a20c977d54981da9955 |
| publicationDate |
2022-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022192482-A1 |
| titleOfInvention |
A medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions |
| abstract |
The exemplary embodiments may modify a glucose cost component of the cost function of the control loop of an insulin delivery device to compensate for persistent positive low level glucose excursions relative to a target glucose level. The exemplary embodiments may enable use of different glucose cost component functions for different glucose levels of the user. These glucose cost component functions may be employed in piecewise fashion with a different piece being applied for each respective range of glucose level values for the user. The final glucose cost function for calculating the glucose cost component may be a weighted combination of a piecewise glucose cost function and a weighted standard cost function (such as a quadratic function). The weights may reflect the magnitude and/or persistence of glucose excursions relative to a target glucose level. |
| priorityDate |
2021-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |